Survey: How Will COVID-19 Shape the Pandemic Vaccine R&D Ecosystem?
[Survey is Now Closed]
Take our survey and help identify key factors driving the unprecedented effort to produce SARS-CoV-2 vaccines that can inform the development of new vaccines to prevent future pandemics, and particularly of a universal influenza vaccine.
[Survey is Now Closed]
The Sabin Vaccine Institute’s Influenzer Initiative invites you to take our survey exploring the scientific and technological response to COVID-19 and its potential influence on future pandemic vaccine R&D.
Are you currently responding to COVID-19 as a researcher, organizational or thought leader, funder, investor, or policymaker? Help us identify key factors driving the unprecedented effort to produce SARS-CoV-2 vaccines that can inform the development of vaccines to prevent future pandemics, including a universal influenza vaccine. We’re seeking insights from individuals across sectors and disciplines on how COVID-era science, technology, and collaboration might be sustained and carried forward.
The ~20-minute survey is open until October 9th 2020: https://www.surveymonkey.com/r/Sabin-COVID-UIV
Your participation in this survey is invaluable to our study and greatly appreciated. All data will be collected and shared anonymously. To supplement the survey, we will conduct select, brief follow-up telephone interviews; if contacted, we hope you will agree to engage with us at your convenience. The survey results will be disseminated in a public report and published through our partnership with Nature Research later this year.
We encourage you to share the above survey link (or use our media toolkit) with your institution for inclusion in any newsletters, social media, or other relevant communications.
Share the survey on Twitter, Facebook, and LinkedIn.
For more information contact flu@sabin.org